Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH ZYDUS LIFESCIENCES WYETH/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 27.7 34.5 80.3% View Chart
P/BV x 11.3 5.8 193.3% View Chart
Dividend Yield % 10.9 0.6 1,835.7%  

Financials

 WYETH   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    WYETH
Mar-14
ZYDUS LIFESCIENCES
Mar-23
WYETH/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,065495 215.2%   
Low Rs553319 173.2%   
Sales per share (Unadj.) Rs289.5170.3 170.0%  
Earnings per share (Unadj.) Rs38.719.8 195.7%  
Cash flow per share (Unadj.) Rs39.926.9 148.2%  
Dividends per share (Unadj.) Rs145.006.00 2,416.7%  
Avg Dividend yield %17.91.5 1,216.3%  
Book value per share (Unadj.) Rs118.5173.0 68.5%  
Shares outstanding (eoy) m22.721,012.20 2.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.82.4 116.9%   
Avg P/E ratio x20.920.6 101.5%  
P/CF ratio (eoy) x20.315.1 134.0%  
Price / Book Value ratio x6.82.4 290.1%  
Dividend payout %374.730.3 1,235.1%   
Avg Mkt Cap Rs m18,381412,144 4.5%   
No. of employees `000NANA-   
Total wages/salary Rs m35924,564 1.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,577172,374 3.8%  
Other income Rs m3474,746 7.3%   
Total revenues Rs m6,925177,120 3.9%   
Gross profit Rs m1,02329,677 3.4%  
Depreciation Rs m277,227 0.4%   
Interest Rs m41,299 0.3%   
Profit before tax Rs m1,33925,897 5.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4605,878 7.8%   
Profit after tax Rs m87920,019 4.4%  
Gross profit margin %15.617.2 90.4%  
Effective tax rate %34.322.7 151.3%   
Net profit margin %13.411.6 115.1%  
BALANCE SHEET DATA
Current assets Rs m3,964100,082 4.0%   
Current liabilities Rs m2,08155,267 3.8%   
Net working cap to sales %28.626.0 110.1%  
Current ratio x1.91.8 105.2%  
Inventory Days Days3550 69.8%  
Debtors Days Days27894 296.8%  
Net fixed assets Rs m878144,776 0.6%   
Share capital Rs m2271,012 22.5%   
"Free" reserves Rs m2,466174,146 1.4%   
Net worth Rs m2,693175,158 1.5%   
Long term debt Rs m250-   
Total assets Rs m4,842244,940 2.0%  
Interest coverage x306.020.9 1,461.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.7 193.0%   
Return on assets %18.28.7 209.7%  
Return on equity %32.611.4 285.7%  
Return on capital %49.415.5 318.3%  
Exports to sales %0.139.2 0.3%   
Imports to sales %34.711.9 291.0%   
Exports (fob) Rs m867,577 0.0%   
Imports (cif) Rs m2,28120,544 11.1%   
Fx inflow Rs m867,577 0.0%   
Fx outflow Rs m2,29820,544 11.2%   
Net fx Rs m-2,29147,033 -4.9%   
CASH FLOW
From Operations Rs m1,18826,888 4.4%  
From Investments Rs m28711,712 2.4%  
From Financial Activity Rs m-4,296-44,004 9.8%  
Net Cashflow Rs m-2,821-5,338 52.8%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 18.4 18.0 101.9%  
FIIs % 0.0 5.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.9 25.0 195.4%  
Shareholders   25,706 306,495 8.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on WYETH vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

WYETH vs Cadila Healthcare Share Price Performance

Period WYETH Cadila Healthcare S&P BSE HEALTHCARE
1-Day -2.27% 1.42% 1.18%
1-Month 18.58% 8.68% -0.75%
1-Year 69.59% 109.28% 61.82%
3-Year CAGR 15.36% 32.67% 18.16%
5-Year CAGR 8.95% 24.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the WYETH share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of WYETH hold a 51.1% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of WYETH, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.